The Netherlands Cancer Institute

Amsterdam, North Holland 1066CX

1 studies enrolling now · 4 studies all time

What they study most

BRAF V600E-mutant Metastatic Colorectal Cancer, Myxoid Liposarcoma of Soft Tissue, Non-small Cell Lung Cancer, Retroperitoneal Liposarcoma

Studies at this site

• Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma — Recruiting now
• Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas — Status unconfirmed